Upgrade to SI Premium - Free Trial

Emergent BioSolutions (EBS)

6.21 -0.02 (0.32%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Emergent BioSolutions buys back $75M in senior unsecured notes September 3, 2026 7:45 AM - StreetInsider Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes September 3, 2026 7:45 AM - StreetInsider Form 8-K Emergent BioSolutions For: Aug 18 September 1, 2026 4:13 PM - SEC Filing Emergent BioSolutions gets $24M BARDA contract for anthrax vaccine September 1, 2026 7:55 AM - StreetInsider Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) September 1, 2026 7:55 AM - StreetInsider Emergent BioSolutions wins Canada NARCAN supply deal through 2029 August 31, 2026 7:55 AM - StreetInsider Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray August 31, 2026 7:55 AM - StreetInsider Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day August 31, 2026 7:54 AM - StreetInsider JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight August 21, 2026 3:28 AM - StreetInsider Form SCHEDULE 13G Emergent BioSolutions Filed by: AMERICAN CENTURY INVESTMENT MANAGEMENT INC August 14, 2026 2:37 PM - SEC Filing Form 3 Emergent BioSolutions For: Aug 05 Filed by: Duatschek Stephanie August 12, 2026 9:17 AM - SEC Filing Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright August 10, 2026 6:49 AM - StreetInsider Form 10-Q Emergent BioSolutions For: Jun 30 August 6, 2026 6:02 AM - SEC Filing Emergent BioSolutions (EBS) Tops Q2 EPS by 49c August 6, 2026 2:17 AM - StreetInsider Emergent BioSolutions highlights biological threat risks amid AI advances August 5, 2026 4:08 PM - StreetInsider Form 8-K Emergent BioSolutions For: Aug 05 August 5, 2026 4:07 PM - SEC Filing Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment August 5, 2026 4:07 PM - Globe NewsWire Emergent BioSolutions Reports Second Quarter 2026 Financial Results August 5, 2026 4:07 PM - StreetInsider Form SCHEDULE 13G/A Emergent BioSolutions Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:21 AM - SEC Filing Form SCHEDULE 13G/A Emergent BioSolutions Filed by: BlackRock, Inc. July 28, 2026 4:45 PM - SEC Filing Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 July 22, 2026 4:01 PM - StreetInsider Form EFFECT Erste Group Bank AG/ADR July 9, 2026 6:04 AM - SEC Filing Form 4 Emergent BioSolutions For: Jul 01 Filed by: Williams Paul Anthony July 2, 2026 12:57 PM - SEC Filing Form F-6 Erste Group Bank AG/ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary July 1, 2026 5:26 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony July 1, 2026 4:13 PM - SEC Filing Form 8-K Emergent BioSolutions For: Jun 26 June 29, 2026 11:15 AM - SEC Filing Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal June 29, 2026 9:13 AM - StreetInsider Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government June 29, 2026 9:13 AM - Globe NewsWire Form 4 Emergent BioSolutions For: Jun 08 Filed by: Williams Paul Anthony June 10, 2026 3:09 PM - SEC Filing Form 4 Emergent BioSolutions For: Jun 08 Filed by: LINDAHL RICHARD S June 10, 2026 3:08 PM - SEC Filing Form 4 Emergent BioSolutions For: Jun 08 Filed by: Glessner Coleen June 10, 2026 3:07 PM - SEC Filing Form 4 Emergent BioSolutions For: Jun 08 Filed by: Hartzel William June 10, 2026 3:06 PM - SEC Filing Full Article List